HomePeripheral vascular diseaseFemoropopliteal

Femoropopliteal

View Category

Femoropopliteal

Safety of Atherectomy in Femoropopliteal Disease

Peripheral artery disease hinders patient quality of life extensively. In advanced stages, such as critical lower limbs...
solaci -
Learn More
Femoropopliteal

Drug Coated Balloons in Femoropopliteal Territory: Predictors of Failed Patency

Endovascular treatment in femoropopliteal territory has become the strategy of choice over time, with diverse devices; among...
solaci -
Learn More
Femoropopliteal

EMINENT Trial | Stent Eluvia vs BMS in Femoropopliteal Territory

Endovascular therapy in femoropopliteal territory has become the standard, mainly with self-expanding stents, aimed at preventing early...
solaci -
Learn More
Femoropopliteal

Results of the COMPARE Study After 2 Years: Low Dose vs. High Dose Paclitaxel-Coated Balloons

The development of new devices and techniques has expanded the range of patients who benefit from endovascular...
solaci -
Learn More
Femoropopliteal

Clinical Results of IVUS-Guided Drug-Eluting Stent Implantation in Femoropopliteal Disease

Endovascular treatment of femoropopliteal lesions has become the first-line treatment due to the development of devices that...
solaci -
Learn More
Femoropopliteal

DISRUPT-PAD III: Followup of IVL Treatment in Femoropopliteal Territory

Femoropopliteal segment calcification can generate complications for both preparation and execution of endovascular therapies for patients with...
solaci -
Learn More
Femoropopliteal

Intermittent Claudication: Invasive Treatment Superior to Pharmacological Treatment?

Peripheral vascular disease is strongly associated to cardiovascular events and a negative impact on health status and...
solaci -
Learn More
Femoropopliteal

IN.PACT Global: Follow Up of Real-Life Patient in Femoropopliteal Territory

Drug coated balloons (DCB) emerged as an innovative treatment approximately 10 years ago. Since then, numerous randomized...
solaci -
Learn More